PBO examines effects of proposed changes to Canadian patented drug regime in new report
The Parliamentary Budget Officer (PBO) has released a report on Canadian Patented Drug Prices: Gauging the Change in Reference Countries that examines the effects of proposed changes to Canada’s drug pricing...To view the full article, register now.
Already a subscriber? Click here to view full article